Protozoal and bacterial cell membrane lipid phase

The protozoal and bacterial cell membrane lipid phase is a fundamental structural component that defines the boundary of the microorganism and regulates the passage of molecules. In bacteria, this lipid bilayer is the site of essential processes including oxidative phosphorylation and the synthesis of cell wall precursors (PubMed: 25130095). Protozoal membranes, while more similar to eukaryotic cells, often possess unique lipid compositions or arrangements that can be exploited therapeutically (PubMed: 15596418). Drugs targeting the lipid phase, such as polymyxins and daptomycin, exert their effects by physically disrupting the membrane's integrity through pore formation or depolarization (PubMed: 15105405). This disruption leads to the catastrophic leakage of cytoplasmic contents and the loss of the proton motive force, resulting in rapid cell death. Because these agents target the physical properties of the membrane rather than a specific protein binding site, they are often effective against multi-drug resistant pathogens. However, the similarity between microbial and host cell membranes can lead to significant toxicity, such as the nephrotoxicity associated with systemic polymyxin use (StatPearls: Polymyxins). Therapeutic challenges include achieving selective toxicity and managing the narrow therapeutic index of membrane-active agents. Despite these challenges, the lipid phase remains a vital target for treating severe infections where other antibiotics have failed.

Other names

Microbial cell membraneBacterial lipid bilayerProtozoal plasma membraneCytoplasmic membrane lipid phase

Direct disruption of the lipid bilayer integrity through insertion, pore formation, or depolarization, leading to leakage of intracellular contents and loss of membrane potential (PubMed: 25130095, 15105405).